GSH reductase (requires riboflavin as a co-factor) regenerates reduced-GSH from its oxidized disulfide (GSSG)
As the primary factors for the reduced anticancer effect 1) the reduced delivery and uptake of the anticancer agent, 2) the need for the conversion of molecular oxygen (O 2 ) into reactive oxygen species (ROS), 3) the preferred therapeutic effect against highly proliferating cells, which is reduced under hypoxic conditions, or 4) adaptation of the cancer cells by promoting cell survival and upregulating certain resistance pathways, has been suggested 1,2,3,4,5
Banach M, Okonski P, Rysz J, Drozdz J, Zaslonka J
Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P: Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics
follow manufacturer guidance